Latest News and Press Releases

SYDNEY, AUSTRALIA and SAN DIEGO, CA--(Marketwire - May 6, 2010) -  Marshall Edwards, Inc. (NASDAQ: MSHL), an oncology company focused on the clinical development of novel anti-cancer...

KANSAS CITY, MO--(Marketwire - May 3, 2010) - A diverse representation of veterinary organizations and individuals ever assembled completed three days of meetings Saturday to examine current...

SYDNEY, AUSTRALIA and SAN DIEGO, CA--(Marketwire - April 29, 2010) - Marshall Edwards, Inc. (NASDAQ: MSHLD), a specialist oncology company focusing on the clinical development of novel anti-cancer...

SYDNEY, AUSTRALIA and SAN DIEGO, CA--(Marketwire - April 26, 2010) - Marshall Edwards, Inc. (NASDAQ: MSHLD), an oncology company focused on the clinical development of novel anti-cancer therapeutics,...

NEW CANAAN, CT--(Marketwire - April 20, 2010) -  Marshall Edwards, Inc. (NASDAQ: MSHL), a specialist oncology company focusing on the clinical development of novel anti-cancer therapeutics, today...

SYDNEY, AUSTRALIA--(Marketwire - March 31, 2010) - Novogen Limited (ASX: NRT) (NASDAQ: NVGN) advises that it has entered into new executive service agreements with its seven most senior executives. ...

NEW CANAAN, CT--(Marketwire - March 31, 2010) - Marshall Edwards, Inc. (NASDAQ: MSHL) (NASDAQ: MSHLD), a specialist oncology company focusing on the clinical development of novel anti-cancer...

DALLAS, TX--(Marketwire - March 25, 2010) -  Congressman Danny K. Davis (Il-7th) recently submitted House Resolution 1179, legislation that puts Congress on record in supporting biotechnology...

NEW CANAAN, CT--(Marketwire - March 19, 2010) -  Marshall Edwards, Inc. (NASDAQ: MSHL), a specialist oncology company focusing on the clinical development of novel anti-cancer therapeutics,...

OSLO, NORWAY--(Marketwire - March 17, 2010) -  Based on encouraging results from pre-clinical research, Bionor Immuno AS today announced intentions to take the therapeutic and potentially...